Cohance Lifesciences Market Cap ($1.92B USD)
Cohance Lifesciences Market Cap ($1.92B USD). As of Nov. 19, 2026, Cohance Lifesciences (COHANCE) market capitalisation is ₹17278.10 Cr ($1.92B), with 37.61 Cr shares outstanding at a current price of ₹459.45 on NSE, ranking 398 out of 5368 companies by market cap in our screener. Cohance Lifesciences operates in the Healthcare sector and is classified as a Mid Cap stock. For live price, earnings and the complete company profile, see COHANCE stock price BSE.
Market Cap History of Cohance Lifesciences (Last 10 Years)
COHANCE market capitalisation from year-end NSE closing prices over the last 10 years. Review COHANCE price earnings ratio to evaluate earnings-based valuation against sector peers.
End of Year Market Cap History — Cohance Lifesciences
COHANCE year-end market cap in INR and USD with closing share price and annual change — NSE closing prices.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹17278.10 Cr
$1.92B USD
|
₹459.45 | NSE | -13.08% |
| 2025 |
₹19878.56 Cr
$2.21B USD
|
₹528.60 | NSE | -53.58% |
| 2024 |
₹42823.89 Cr
$4.76B USD
|
₹1138.75 | NSE | +57.55% |
| 2023 |
₹27181.65 Cr
$3.02B USD
|
₹722.80 | NSE | +46.05% |
| 2022 |
₹18611.23 Cr
$2.07B USD
|
₹494.90 | NSE | +0.33% |
| 2021 |
₹18549.18 Cr
$2.06B USD
|
₹493.25 | NSE | +9.05% |
| 2020 |
₹17009.22 Cr
$1.89B USD
|
₹452.30 | NSE | +150666.67% |
| 2015 |
₹11.28 Cr
$1.25M USD
|
₹0.30 | NSE | - |